← Browse by Condition
Medical Condition
medulloblastoma recurrent
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT03911388 Phase 1
Recruiting
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT01356290 Phase 2
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Enrollment
232 pts
Location
United States, Austr...
Sponsor
Medical University of Vienna